Company / Revenue
Bone Biologics Corp Revenue History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.1B
FY2020
5-year range
$1.1B / $1.1B
FY2017-FY2020
Trend
+0.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue remained relatively stable over the past 4 years, with values between $1.1B and $1.1B.
Based on SEC 10-K filings.
$1.1B in FY2020 with a 3-year CAGR of +0.0%.
Remained stable around $1.1B over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +0.0%, indicating consistent growth.
- In FY2020, revenue increased 0.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $1.1B | +0.0% |
| FY2019 | $1.1B | +0.0% |
| FY2018 | $1.1B | +0.0% |
| FY2017 | $1.1B | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026